Vivoryon Therapeutics AG's total assets for Q2 2024 were €16.99M, a decrease of -44.89% from the previous quarter. DE:05Y total liabilities were €3.01M for the fiscal quarter, a -33.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.